Author(s): Malden DE, Hong V, Lewin BJ, Ackerson BK, Lipsitch M, Lewnard JA, Tartof SY|Journal: MMWR Morb Mortal Wkly Rep|PMID:35737591| June 2022
Nirmatrelvir/ritonavir (Paxlovid) is a combination protease inhibitor that blocks replication of SARS-CoV-2 (the virus that causes COVID-19) and has been…
Author(s): Lewnard JA, Hong VX, Patel MM, Kahn R, Lipsitch M, Tartof SY|Journal: Nat Med|PMID:35675841| June 2022
Epidemiologic surveillance has revealed decoupling of COVID-19 hospitalizations and deaths from case counts following emergence of the Omicron (B.1.1.529) SARS-CoV-2…
Author(s): Lewnard JA, Hanage WP|Journal: Lancet Infect Dis|PMID:30709666| February 2019
Serotype replacement in invasive pneumococcal disease threatens to undermine the most costly vaccination programme currently undertaken. However, the effects of…
Author(s): Lewnard JA, Tedijanto C, Cowling BJ, Lipsitch M|Journal: Am J Epidemiol|PMID:30099505| December 2018
Test-negative designs are commonplace in assessments of influenza vaccination effectiveness, estimating this value from the exposure odds ratio of vaccination…
Author(s): Lewnard JA, Tähtinen PA, Laine MK, Lindholm L, Jalava J, Huovinen P, Lipsitch M, Ruohola A|Journal: J Infect Dis|PMID:29873739| September 2018
Despite concerns that antimicrobial treatment of prevalent infections may select for drug-resistant bacteria, the effects of antimicrobial treatment on colonization…